Stroke in the Middle-East and North Africa: A 2-year prospective observational study of intravenous thrombolysis treatment in the region. Results from the SITS-MENA Registry.
S Al-RuknM MazyaN AkhtarH HashimB MansouriB FaouziH ArefH AbdulrahmanS KesraouiF HentatiS GebellyN AhmedN WahlgrenF Abd-AllahM AlmekhlafiTiago T P MoreiraPublished in: International journal of stroke : official journal of the International Stroke Society (2019)
Intravenous thrombolysis patients in MENA were younger, had more severe strokes and more often diabetes. Although stroke severity was higher in MENA, short-term functional independency and mortality were not worse compared to non-MENA, which could partly be explained by younger age and shorter OTT in MENA. Decreasing the burden of stroke in this young population should be prioritized.
Keyphrases
- atrial fibrillation
- pulmonary embolism
- end stage renal disease
- type diabetes
- ejection fraction
- high dose
- newly diagnosed
- acute ischemic stroke
- chronic kidney disease
- risk factors
- peritoneal dialysis
- cardiovascular events
- early onset
- coronary artery disease
- cerebral ischemia
- metabolic syndrome
- adipose tissue
- tertiary care
- combination therapy